220 2023 trento English-speaking jobs in Lombardy

In 2023, we employed around 4,400 people and generated revenues of €1.8 billion. #J-18808-Ljbffr

Italian Paralympic Committee, the Regions of Lombardy and Veneto, as well as the Autonomous Provinces of Trento

In 2023, it established a new Italian trading company, Ardonagh Italia, to drive forward Ardonagh’s growth

Awards * Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

In 2023, Chart acquired Howden, a global engineering business with a history dating back to 1854.

In 2023, Ardonagh established a new Italian trading company, Ardonagh Italia, to advance its growth strategy

In 2023, we joined MEDIA Central Group and are now a partner to over 500 top retailers and brands in

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Awards * Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

share), and related legislation (e.g., budget laws, Abruzzo decree, tender frameworks such as d.lgs 36/2023

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Thorough knowledge of Legislative Decree 36/2023 (Public Contracts Code) and main e-procurement platforms

With over 55 years of heritage, 340,000 team members across more than 50 countries, and 2023 revenues

On September 14th, 2023, it was announced that Future Electronics would be joining forces with WT Microelectronics

Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice ... Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023